Calando Pharmaceuticals, Inc.

Pasadena, CA 91101

SBIR Award Summary

Total Number of Awards 1
Total Value of Awards $100K
First Award Date 03/01/06
Most Recent Award Date 03/01/06

Key Personnel

Last Name Name Awards Contact
Heidel Jeremy D. Heidel 1

1 Award Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-05-41
Budget: 03/01/06 - 02/28/07

DESCRIPTION (provided by applicant): Gene silencing by RNA interference (RNAi) is rapidly becoming the method of choice for the elucidation of gene function and the identification of therapeutic targets. RNAi is envisioned to ultimately be used as a potent and selective human therapeutic. Short interfering RNAs (siRNA) can be chemically synthesi...